Lanean...
Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices
Tolvaptan is an effective therapy for heart failure patients with symptomatic congestion and hyponatremia. The efficacy of its use in patients with continuous-flow left ventricular assist devices (LVADs) is unknown. The aim of this study was to assess the clinical efficacy and safety of tolvaptan in...
Gorde:
| Argitaratua izan da: | ASAIO J |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7340106/ https://ncbi.nlm.nih.gov/pubmed/31567410 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MAT.0000000000001079 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|